SubsidieMeestersTranslational Microbiome Platform
MICK is a digital decision support system that automates microbiome analysis for healthcare professionals, reducing costs by 75% and speeding up turnaround times for clinical applications.
Projectdetails
Introduction
Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess, and monitor it.
Challenges in Microbiome Analysis
Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming.
MICK: A Solution
We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice.
Features of MICK
MICK's automated platform:
- Analyzes microbiome raw data in real-time
- Provides the highest accuracy
- Translates data into evidence-based analytics, insights, and practical recommendations
Benefits for Customers
MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining:
- Up to 75% cost reduction
- Faster turnaround time (TAT) compared to existing solutions
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.156.681 |
| Totale projectbegroting | € 3.080.973 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 28-2-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- SEQUENTIA BIOTECH SLpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
World’s first diagnostic test that can detect all bacterial species in a single assayInbiome aims to implement the "Molecular Culture" diagnostic test in hospitals to accurately identify bacterial infections within 4 hours, enhancing treatment and reducing costs. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare.VMS is a home-based gynaecological test kit that uses tampons for accurate STI and HPV screening, offering comprehensive aftercare and insights into vaginal health. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Pioneering diagnostics in dermatology and cancerDermagnostix aims to enhance dermatological diagnostics with a rapid, automated platform for precise molecular testing, reducing misdiagnoses and improving patient care. | EIC Accelerator | € 2.499.000 | 2022 | Details |
World’s first diagnostic test that can detect all bacterial species in a single assay
Inbiome aims to implement the "Molecular Culture" diagnostic test in hospitals to accurately identify bacterial infections within 4 hours, enhancing treatment and reducing costs.
Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare.
VMS is a home-based gynaecological test kit that uses tampons for accurate STI and HPV screening, offering comprehensive aftercare and insights into vaginal health.
Pioneering diagnostics in dermatology and cancer
Dermagnostix aims to enhance dermatological diagnostics with a rapid, automated platform for precise molecular testing, reducing misdiagnoses and improving patient care.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MicroBioDx: karakterisatie van microbioom-gastheer interactiesTenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren. | Mkb-innovati... | € 143.080 | 2021 | Details |
Microbial ecosystems biology in the human gutThis project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions. | ERC Starting... | € 1.485.413 | 2023 | Details |
Microbiome-based diagnostics and therapeuticsThis project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression. | ERC Proof of... | € 150.000 | 2023 | Details |
A metagenomic-based precision-medicine tool for personalized diagnosis, prognosis and treatment of oral diseasesPreBiomicsPMT aims to develop an automated precision-medicine test using metagenomics and AI to assess peri-implant plaque microbiomes, enhancing diagnosis and treatment for dental implant patients. | EIC Transition | € 2.461.900 | 2023 | Details |
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modellingThis project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions. | ERC Starting... | € 1.499.323 | 2024 | Details |
MicroBioDx: karakterisatie van microbioom-gastheer interacties
TenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren.
Microbial ecosystems biology in the human gut
This project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions.
Microbiome-based diagnostics and therapeutics
This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.
A metagenomic-based precision-medicine tool for personalized diagnosis, prognosis and treatment of oral diseases
PreBiomicsPMT aims to develop an automated precision-medicine test using metagenomics and AI to assess peri-implant plaque microbiomes, enhancing diagnosis and treatment for dental implant patients.
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling
This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.